Jiang et al.
FULL PAPER
2H), 2.43 (s, 3H), 2.22 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ: 144.0, 136.2, 136.2, 132.8, 132.1, 130.1,
129.6, 127.8, 126.6, 126.3, 124.4, 119.7, 56.9, 21.6,
methylbenzenesulfonamide (2j): Colorless oil; 1H NMR
(400 MHz, CDCl3) δ: 7.83 (d, J=8.3 Hz, 2H), 7.57 (d,
J=8.8 Hz, 2H), 7.30 (d, J=8.0 Hz, 2H), 6.86 (d, J=
8.9 Hz, 2H), 5.79—5.75 (m, 1H), 5.04 (s, br, 1H),
4.83—4.81 (m, 1H), 3.81 (s, 3H), 2.43 (s, 3H), 1.95—
1.59 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 159.9,
143.6, 137.4, 131.9, 129.5, 127.7, 127.6, 114.3, 59.7,
55.3, 24.3, 21.5, 21.3; IR (film) ν: 1590, 1492, 1346,
-
1
18.8; IR (film) ν: 1352, 1166, 827, 812, 659 cm ;
EI-MS (relative intensity) m/z (%): 333 (27), 178 (80),
137 (40), 123 (74), 91 (100), 65 (46), 45 (69); HRMS
calcd for C17H19NO2S2Na (M+Na)+: 356.0749, found
356.0749.
-
1
N-Allyl-N-(4-chlorophenylthio)-4-methylbenzenesul-
fonamide (2d): White solid, m.p. 64—65 ℃; H NMR
1251, 1160, 1083, 1028, 873, 854, 812, 729, 665 cm ;
EI-MS (relative intensity) m/z (%): 389 (5), 309 (36),
154 (100), 139 (74), 91 (56), 65 (26); HRMS calcd for
C20H24NO3S2 (M+H)+: 390.1192, found 390.1191.
N-Allyl-N-(butylthio)-4-methylbenzenesulfonamide
(2k): Colorless oil; 1H NMR (400 MHz, CDCl3) δ: 7.80
(d, J=8.3 Hz, 2H), 7.30 (d, J=8.2 Hz, 2H), 5.77 (tdd,
J=6.5, 6.5, 10.08, 16.7 Hz, 1H), 5.19 (ddd, J=1.3,
10.9, 8.7 Hz, 2H), 4.04 (d, J=6.5 Hz, 2H), 2.88 (t, J=
7.4 Hz, 2H), 2.43 (s, 3H), 1.59—1.52 (m, 2H),
1.43—1.36 (m, 2H), (t, J=7.33, 7.33 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ: 143.6, 136.0, 133.1, 129.4,
127.8, 119.1, 57.6, 39.8, 29.1, 21.8, 21.5, 13.6; IR (film)
1
(400 MHz, CDCl3) δ: 7.80 (d, J=8.3 Hz, 2H), 7.36—
7.26 (m, 6H), 5.70 (tdd, J=6.5, 6.5, 10.1, 16.7 Hz, 1H),
5.19—5.13 (m, 2H), 4.13 (d, J=6.5 Hz, 2H), 2.44 (s,
1H); 13C NMR (100 MHz, CDCl3) δ: 144.2, 136.0,
135.6, 133.5, 132.2, 129.6, 129.0, 128.0, 127.7, 119.9,
77.3, 77.0, 76.7, 57.0, 21.5; IR (film) ν: 1474, 1349,
-
1
1086, 812, 659 cm ; EI-MS (relative intensity) m/z (%):
353 (11), 198 (49), 143 (68), 91 (100), 108 (30), 65 (46);
HRMS calcd for C16H16ClNO2S2Na (M + Na)
376.0202, found 376.0203.
N-Allyl-N-(4-methoxyphenylthio)-4-methylbenzene-
sulfonamide (2e): Colorless oil; H NMR (400 MHz,
CDCl3) δ: 7.79 (d, J=8.3 Hz, 1H), 7.52 (d, J=8.9 Hz,
2H), 7.30 (d, J=8.0 Hz, 2H), 6.85 (d, J=8.9 Hz, 2H),
5.72 (tdd, J=6.4, 6.4, 10.1, 16.5 Hz, 1H), 5.17 (ddd,
J=1.3, 9.3, 7.1 Hz, 2H), 4.08 (d, J=6.4 Hz, 2H), 3.81
(s, 3H), 2.43 (s, 3H); 13C NMR (100 MHz, CDCl3)
δ: 160.6, 143.7, 136.5, 133.6, 132.9, 129.5, 127.7, 126.5,
119.1, 114.4, 56.3, 55.3, 21.5; IR (film) ν: 1590, 1492,
1346, 1245, 1086, 824, 812, 662 cm ; EI-MS (relative
intensity) m/z (%): 349 (12), 194 (56), 139 (100), 91
(50); HRMS calcd for C17H19NO3S2Na (M+Na)+:
372.0698, found 372.0699.
+
:
-
1
1
ν: 1345, 1160, 1089, 912, 827, 812, 732, 662 cm ;
EI-MS (relative intensity) m/z (%): 299 (30), 344 (52),
103 (70), 91 (100), 65 (44), 56 (97), 41 (70), 29 (53);
HRMS calcd for C14H21NO2S2Na (M+Na)+: 322.0907,
found 322.0906.
N-Allyl-N-(benzylthio)-4-methylbenzenesulfonamide
(2l): White solid, m.p. 52—53 ℃; 1H NMR (400 MHz,
CDCl3) δ: 7.82 (d, J=8.3 Hz, 2H), 7.32—7.26 (m, 7H),
5.52 (tdd, J=6.5, 6.5, 10.4, 16.8 Hz, 1H), 5.06—5.01
(m, 2H), 4.10 (s, 2H), 3.81 (d, J=6.4 Hz, 2H), 2.42 (s,
3H); 13C NMR (100 MHz, CDCl3) δ: 143.7, 136.2,
134.9, 132.7, 129.7, 129.4, 128.6, 127.8, 127.6, 118.9,
57.2, 44.8, 21.5; IR (film) ν: 1349, 1160, 1086, 925, 827,
812, 711, 699, 662 cm ; EI-MS (relative intensity) m/z
(%): 333 (10), 123 (20), 91 (100), 65 (19); HRMS calcd
for C17H19NO2S2Na (M +Na) + : 356.0749, found
356.0741.
N-(1-Bromobut-3-en-2-yl)-4-methyl-N-(phenylthio)-
benzenesulfonamide (2m): White solid, m.p. 83—84 ℃;
1H NMR (400 MHz, CDCl3) δ: 7.83 (d, J=8.3 Hz, 2H),
7.52 (d, J=7.4 Hz, 2H), 7.34—7.23 (m, 5H), 5.64 (ddd,
J=7.8, 10.3, 17.3 Hz, 1H), 5.15 (d, J=10.4 Hz, 2H),
4.91 (q, J=7.4, 7.4, 7.7 Hz, 1H), 3.45 (dd, J=6.9, 10.4
Hz, 1H), 3.34 (t, J=8.7, 8.7 Hz, 1H), 2.42 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ: 144.2, 137.7, 136.1, 133.2,
129.4, 128.9, 128.1, 127.7, 126.6, 120.6, 66.0, 32.1,
21.6; IR (film) ν: 1358, 1163, 1086, 888, 836, 812, 741,
-
1
N-(4-Chlorophenylthio)-N-(cyclohex-2-enyl)-4-meth-
ylbenzenesulfonamide (2f): White solid, m.p. 79—80
-
1
1
℃; H NMR (400 MHz, CDCl3) δ: 7.84 (d, J=8.3 Hz,
2H), 7.40 (d, J=8.6 Hz, 2H), 7.33—7.27 (m, 4H),
5.77—5.73 (m, 1H), 4.92 (br s, 2H), 2.24 (s, 3H),
1.91—1.54 (m, 6H); 13C NMR (100 MHz, CDCl3)
δ: 144.1, 132.6, 129.7, 128.8, 127.6, 126.8, 59.8, 24.2,
21.5, 21.1; IR (film) ν: 1474, 1355, 1166, 1086, 873,
-
1
814, 729, 665 cm ; EI-MS (relative intensity) m/z (%):
393 (12), 313 (66), 91 (100), 65 (44), 41 (42); HRMS
calcd for C19H20ClNO2S2Na (M +Na) + : 416.0516,
found 416.0512.
N-(Cyclohex-2-enyl)-4-methyl-N-(phenylthio)ben-
zenesulfonamide (2i): White solid, m.p. 101—102 ℃;
1H NMR (400 MHz, CDCl3) δ: 7.85 (d, J=8.3 Hz, 2H),
7.44 (d, J=7.5 Hz, 2H), 7.33—7.30 (m, 4H), 7.21—
7.17 (m, 1H), 5.75—5.72 (m, 1H), 4.93—4.91 (m, 2H),
2.24 (s, 3H), 1.90—1.57 (m, 6H); 13C NMR (100 MHz,
CDCl3) δ: 143.9, 137.0, 137.0, 132.4, 129.6, 128.7,
127.6, 127.0, 126.6, 124.8, 59.8, 24.2, 21.5, 21.2; IR
(film) ν: 1355, 1163, 873, 854, 812, 665 cm ; EI-MS
(relative intensity) m/z (%): 359 (2), 279 (59), 124 (100),
109 (37), 91 (66), 81 (34), 65 (44); HRMS calcd for
C19H21NO2S2Na (M+Na)+: 382.0906, found 382.0905.
N-(Cyclohex-2-enyl)-N-(4-methoxyphenylthio)-4-
-
1
668 cm ; EI-MS (relative intensity) m/z (%): 413 (8),
411 (7), 258 (37), 256 (36), 124 (44), 109 (69), 91 (100),
65(63); HRMS calcd for C17H18BrNO2S2Na (M+Na)+:
433.9855, found 433.9847.
N-(1-Hydroxybut-3-en-2-yl)-4-methyl-N-(phenyl-
thio)benzenesulfonamide (2n): White solid, m.p.
-
1
1
107—108 ℃; H NMR (400 MHz, CDCl3) δ: 7.83 (d,
J=8.3 Hz, 2H), 7.58 (s, 2H), 7.36—7.24 (m, 5H), 5.56
(ddd, J=8.0, 10.0, 17.6 Hz, 1H), 5.09 (d, J=10.5 Hz,
2H), 4.81 (dt, J=5.3, 8.0, 7.7 Hz, 1H), 3.70 (t, J=10.0,
2034
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2012, 30, 2029—2035